N-(3-((5-Chloro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)pyrimidin-4-yl)amino)phenyl)acetamide

ID: ALA4647703

PubChem CID: 146047137

Max Phase: Preclinical

Molecular Formula: C22H25ClN8O

Molecular Weight: 452.95

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C)CC4)cn3)ncc2Cl)c1

Standard InChI:  InChI=1S/C22H25ClN8O/c1-15(32)26-16-4-3-5-17(12-16)27-21-19(23)14-25-22(29-21)28-20-7-6-18(13-24-20)31-10-8-30(2)9-11-31/h3-7,12-14H,8-11H2,1-2H3,(H,26,32)(H2,24,25,27,28,29)

Standard InChI Key:  GVJLKAACQAJVQS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   32.8554  -27.0168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8543  -27.8363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5623  -28.2453    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2720  -27.8359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2692  -27.0132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5606  -26.6079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9804  -28.2433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9753  -26.6019    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   32.1463  -28.2444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4389  -27.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4441  -27.0181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7375  -26.6091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0285  -27.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0305  -27.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7376  -28.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3206  -26.6089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3201  -25.7918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6131  -27.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9052  -26.6097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6122  -25.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9047  -25.7925    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1968  -25.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6874  -27.8336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3925  -28.2416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0990  -27.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0982  -27.0145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3849  -26.6072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6812  -27.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8072  -28.2404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5145  -27.8310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2226  -28.2388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5136  -27.0138    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  5  8  1  0
  2  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 17 20  1  0
 19 21  1  0
 21 20  1  0
 21 22  1  0
  7 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 25 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
M  END

Alternative Forms

  1. Alternative Forms:

    ALA4647703

    ---
  2. Parent:

    ALA4647703

    ---

Associated Targets(Human)

CCND3 Tchem CDK6/cyclin D3 (897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK9 Tchem CDK9/Cyclin K (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem CDK3/Cyclin E (905 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK19 Tchem Cyclin-C/Cyclin-dependent kinase 19 (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK6 Tclin Cyclin-dependent kinase 6 (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.95Molecular Weight (Monoisotopic): 452.1840AlogP: 3.72#Rotatable Bonds: 6
Polar Surface Area: 98.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.64CX Basic pKa: 7.65CX LogP: 3.38CX LogD: 2.93
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.52Np Likeness Score: -1.78

References

1. Wang Y, Chen X, Yan Y, Zhu X, Liu M, Liu X..  (2020)  Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity.,  63  (6): [PMID:32129996] [10.1021/acs.jmedchem.9b02121]

Source